IMMUNO-ONCOLOGY INSIGHTS

Addressing lingering safety issues for I-O product candidates in development

Guest Editor:
Ashok Gupta, MD, PhD, Global Clinical Head, Imfinzi Genitourinary Cancers and Tumor Agnostic Indications at AstraZeneca
Ashok Gupta
MD, PhD, Global Clinical Head, Imfinzi Genitourinary Cancers and Tumor Agnostic Indications at AstraZeneca
December 2020